Skip to main content

Table 1 Patient and tumor sample characteristics

From: Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma

Variable

Overall N = 64

p-value

Age at diagnosis (in years)

55 (+/−15.1)

0.3

Sex

 

0.6

 Male

25 (39%)

 Female

39 (61%)

Race a

 

0.7

 White

40 (62.5%)

 Asian/PI

17 (26.6%)

 African American and Other

07 (10.9%)

Smoking history b

 

0.1

 No

37 (57.8%)

 Yes

20 (31.3%)

 Missing

07 (11.0%)

 

Tumor stage c

 

0.005

 Early (Stage 2 or earlier)

22 (31.3%)

 Late (Stage 3 or later)

36 (56.3%)

 Missing

08 (12.5%)

 

Tumor location

 

0.04

 Major salivary gland

19 (29.7%)

 Minor salivary gland

45 (70.3%)

Perineural invasion d

 

0.1

 Yes

41 (64.1%)

 No

11 (17.9%)

 Missing

12 (18.8%)

 

Margin status e

 

0.2

 Negative

06 (09.4%)

 Positive

45 (70.3%)

 Missing

13 (20.3%)

 

Dominant pattern

 

0.3

 Tubular/Cribriform

43 (67.2%)

 Solid

15 (20.3%)

 Missing

08 (12.5%)

 

Tumor necrosis

13 (20.3%)

0.3

Treatment f

 

0.3

 Surgery

17 (26.6%)

 Surgery +RT/C or RT/C alone

47 (73.4%)

 Missing

01 (1.34%)

 
  1. aThere were very few African American patients in our sample; thus, we combined them with people who disclosed their race as other, who were also few.
  2. bPatients were categorized as smokers if they reported current or formerly smoking.
  3. cTumor stages were determined clinically using TNM tumor classification.
  4. dPerineural invasion was determined histologically.
  5. eAll patients in our study received some treatment. We dichotomized them in two categories: those patients who received surgical treatment and those who underwent radiation therapy (RT) and chemotherapy (C) in addition to surgery or independent of surgical treatment.
Back to article page

Journal of Otolaryngology - Head & Neck Surgery

ISSN: 1916-0216

Contact us